Skip to main content

King’s People

Dr Michael Robson PhD

Academics

Consultant nephrologist

Contact details

michael.robson@kcl.ac.uk

Pronouns

him

Biography

Dr Robson is a consultant nephrologist at Guy’s and St Thomas’ with a clinical interest in glomerulonephritis and vascular access for haemodialysis. He is a lead nephrologist in a clinic with one of the largest cohorts of patients with lupus nephritis in the UK, and works closely with rheumatologists specialising in lupus.

From 2017 - 2021 he was Chair of the UK Kidney Association Clinical Practice Guidance committee. Fifty percent of his time is spent on clinical work. Previous research has been laboratory-based with the aim of understanding the mechanisms of disease in glomerulonephritis in order to discover new treatments. He was also the Chief Investigator in the PAVE trial, a multi-centre clinical trial funded by the National Institute for Health Research, aimed at preserving vascular access for haemodialysis.

Currently he is developing clinical trials in both vascular access and lupus nephritis. He is also the local investigator for a number of commercial trials in lupus nephritis and IgA nephropathy. He is keen to hear from clinical trainees interested in research on lupus nephritis or vascular access.

Latest publications

Circulating Interleukin-6 and CD16 positive monocytes increase following angioplasty of an arteriovenous fistula
Hakki, S., Robinson, E. J. & Robson, M. G., Dec 2022, In: Scientific Reports. 12, 1, 1427. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41598-022-05062-9
Manipulation of Tissue Factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH.
Wilkinson, H., Leonard, H., Robson, M., Smith, R., Tam, E., McVey, J. H., Kirchhofer, D., Chen, D. & Dorling, A., 12 Sep 2022, In: Frontiers in immunology. 13, 999871. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3389/fimmu.2022.999871
The lectin pathway does not contribute to glomerular injury in the nephrotoxic nephritis model
Freeley, S. J., Tham, E. L. & Robson, M. G., Feb 2022, In: NEPHROLOGY. 27, 2, p. 208-214 7 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/nep.13988
Experimentally induced anti-myeloperoxidase vasculitis is not attenuated in factor B or VISTA deficient mice
Flórez-Barrós, F., Freeley, S. J., Tham, E-L. & Robson, M. G., 13 Nov 2021, (Accepted/In press) In: Glomerular Diseases. Research output: Contribution to journal › Article › peer-review
Paclitaxel-assisted balloon angioplasty of venous stenosis in haemodialysis access: PAVE RCT
Karunanithy, N., Robinson, E. J., Calder, F., Dorling, A., Peacock, J., Wang, Y., Gardner, L. M. & Robson, M., 27 Sep 2021, In: Efficacy and Mechanism Evaluation. 8, 13 Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.3310/eme08130
A multicenter randomized controlled trial indicates that paclitaxel-coated balloons provide no benefit for arteriovenous fistulas
Karunanithy, N., Robinson, E. J., Ahmad, F., Burton, J. O., Calder, F., Coles, S., Das, N., Dorling, A., Forman, C., Jaffer, O., Lawman, S., Lakshminarayan, R., Lewlellyn, R., Peacock, J. L., Ramnarine, R., Mesa, I. R., Shaikh, S., Simpson, J., Steiner, K., Suckling, R., & 8 othersSzabo, L., Turner, D., Wadoodi, A., Wang, Y., Weir, G., Wilkins, C. J., Gardner, L. M. & Robson, M. G., Aug 2021, In: Kidney International. 100, 2, p. 447-456 10 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.kint.2021.02.040
Human marginal zone B cell development from early T2 progenitors
Spencer, J., Tull, T., Pitcher, M., Guesdon, W., Siu, J. HY., Lebraro-Fernandez, C., Zhao, Y., Petrov, N., Heck, S., Ellis, R., Dhami, P., kadolsky, U., Kleeman, M., Kamra, Y., Fear, D., John, S., Jassem, W., Groves, R., Sanderson, J. D., Robson, M., & 2 othersD’Cruz, D. & Bemark, M., 5 Apr 2021, In: Journal of Experimental Medicine. 218, 4, e20202001. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1084/jem.20202001
PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses
Wilkinson, H., Leonard, H., Chen, D., Lawrence, T., Robson, M., Goossens, P., McVey, JH. & Dorling, A., 22 Jan 2021, In: iScience. 24, 1, 101981. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.isci.2020.101981
The authors reply
Robson, M., 2021, In: Kidney International. Research output: Contribution to journal › Letter › peer-review. DOIs: https://doi.org/10.1016/j.kint.2021.05.019
VISTA deficiency protects from immune complex-mediated glomerulonephritis by inhibiting neutrophil activation
Tham, E. L., Freeley, S., Bearder, S., Florez Barros, F., Cragg, M. S., Mocsai, A. & Robson, M., 30 Sep 2020, In: Journal of Autoimmunity. 113, p. 102501 Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/j.jaut.2020.102501

View all publications